If an orforglipron dose is missed by fourteen days, does the ladder reset?

Concretely: orforglipron · fourteen days.

This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory.

What I have done so far is read the label documentation where it exists and the two pharmacopoeial monographs that are publicly available, which cover the licensed presentation and say nothing about a research one.

What is the correct sequence, and where is the step that people usually skip?

14 days past a due dose is 2 half-lives at the seven-day half-life this class runs on, which leaves about 25 per cent of that dose still circulating. One line of arithmetic: remaining fraction is one half raised to days over half-life, so 0.5^(14÷7) = 0.25. At 25 per cent you have not been off it in any meaningful sense. The interval stretched from 7 days to 21 and the trough went lower than usual; that is the whole of what happened. What the product label says and what the pharmacokinetics say are two different answers here, and the first is the one that governs. Restarting, holding or stepping down after a gap is decided under supervision, and nothing here is medical advice.

Start with the interval since the missed dose, because that single number determines the answer.

Never take two doses close together to compensate. The peak exposure is roughly doubled, and gastrointestinal tolerability tracks peak exposure closely.

Specifically, with a one-week half-life dosed weekly, missing one dose means exposure falls by about half over the following week — the same trough you would reach if you simply extended the interval. That is well within the range the agent operates in.

Loss of tolerance during a treatment gap is documented and is the basis for re-titration after an interruption.

Never double up. Peak exposure is what drives the symptoms.

Specifically, changing the regular dosing day is possible and should be done by moving forward, not by squeezing two doses together.

The published guidance for the weekly agents is broadly: if the missed dose is remembered within about five days, take it and continue on the usual day; if more than five days have passed, skip it and take the next scheduled dose.

Stated carefully, to change your regular dosing day, move the next dose later rather than earlier, keeping at least three days between doses for a weekly agent. Moving earlier compresses the interval and raises exposure.

Half-lives across the class span roughly thirteen hours to one week, which is why the answer is agent-specific.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Two or more missed weekly doses means considering a lower restarting step.

Answering this needs the agent, since the answer for a thirteen-hour half-life and a one-week half-life are entirely different.

If more than two consecutive weekly doses are missed, tolerance to the gastrointestinal effects begins to fade and re-titration from a lower step becomes the sensible approach.

One missed dose is not a reason to change the schedule or the dose. Two or more is a reason to consider where you are restarting from.

Repeated missed doses are a different problem from an occasional one and should be treated as such.

To move your dosing day, move it later and keep three days between doses.

Answer first: it depends on the half-life and on how long ago the dose was due, and for a weekly agent the tolerance is much wider than people fear.

For a daily agent with a thirteen-hour half-life, a missed dose is a much larger proportional loss. The usual approach is to skip it and take the next scheduled one rather than doubling.

Peak exposure rather than average exposure drives gastrointestinal tolerability, which is the reason doubling up is advised against.

The caveat is that anyone on other glucose-lowering medication has an interaction question here that needs a prescriber.

Within about five days for a weekly agent, take it. Beyond that, skip and resume.

The short version: for a weekly agent, take it if you are within a few days; if you are close to the next scheduled dose, skip it and resume.

Set a recurring reminder tied to something you already do weekly. The commonest cause of a missed dose is not forgetting the drug but losing track of the day.

Published missed-dose guidance for the weekly agents in this class specifies a window of about five days, derived directly from the half-life.

A published missed-dose window applies to a licensed product with a known content, which unverified material is not.

Set a recurring reminder attached to something you already do weekly.